Smith Chas P & Associates Pa Cpas / AMGN
Smith Chas P & Associates Pa Cpas’s Amgen Inc Position
Does Smith Chas P & Associates Pa Cpas own Amgen Inc (AMGN)? Yes — 119.0K shares worth $42M (+2.27% of its 13F portfolio) as of Q1 2026, up from 118.3K shares the prior filed quarter.
Position Value
$42M
Q1 2026
Shares
119.0K
% of Portfolio
+2.27%
Quarters Held
30
currently held
Position History AMGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 119.0K | $42M | +2.27% |
| Q4 2025 | 118.3K | $39M | +2.04% |
| Q3 2025 | 69.3K | $20M | +1.69% |
| Q2 2025 | 116.7K | $33M | +1.83% |
| Q1 2025 | 114.4K | $36M | +2.07% |
| Q4 2024 | 111.5K | $29M | +1.67% |
| Q3 2024 | 110.9K | $36M | +2.01% |
| Q2 2024 | 113.7K | $36M | +2.11% |
| Q1 2024 | 112.0K | $32M | +1.92% |
| Q4 2023 | 108.8K | $31,348 | +2.07% |
| Q3 2023 | 106.0K | $28,479 | +2.07% |
| Q2 2023 | 97.5K | $21,638 | +1.39% |
| Q1 2023 | 1.3K | $303 | +0.02% |
| Q4 2022 | 1.3K | $342 | +0.02% |
| Q3 2022 | 1.9K | $424,000 | +0.04% |
| Q2 2022 | 1.7K | $421,000 | +0.03% |
| Q1 2022 | 1.7K | $408,000 | +0.03% |
| Q4 2021 | 1.1K | $249,000 | +0.02% |
| Q3 2021 | 1.7K | $358,000 | +0.03% |
| Q2 2021 | 1.7K | $409,000 | +0.03% |
| Q1 2021 | 1.7K | $417,000 | +0.04% |
| Q4 2020 | 1.7K | $386,000 | +0.04% |
| Q3 2020 | 1.7K | $424,000 | +0.05% |
| Q2 2020 | 1.7K | $393,000 | +0.05% |
| Q1 2020 | 1.6K | $319,000 | +0.04% |
| Q4 2019 | 1.5K | $359,000 | +0.04% |
| Q3 2019 | 1.5K | $289,000 | +0.03% |
| Q2 2019 | 1.5K | $275,000 | +0.03% |
| Q1 2019 | 1.4K | $262,000 | +0.03% |
| Q4 2018 | 1.3K | $249,000 | +0.03% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Smith Chas P & Associates Pa Cpas’s full portfolio or all institutional holders of AMGN.